Ketamine Reformulation Development | Bexson Biomedical | Ketamine Therapy | Pain Management | Biomedical Researchers
Location: United States, California, Santa Barbara
Employees: 11-50
Total raised: $4.8M
Founded date: 2016
Investors 5
| Date | Name | Website |
| - | Ambria Cap... | ambriacap.... |
| 10.07.2026 | Audrey Cap... | audrey.co |
| - | Noetic Fun... | noeticfund... |
| - | PsyMed Ven... | psymed.ven... |
| - | Vine Ventu... | vine.vc |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 02.02.2021 | Series A | $4.8M | - |
Mentions in press and media 3
| Date | Title | Description |
| 12.08.2021 | Bexson Biomedical Launches New Project, Applying Subcutaneous Delivery Technology To Multiple Psychedelic Compounds For Therapeutic Use | |
| 03.02.2021 | Bexson Biomedical Raises $4.8M In Series A Funding | Bexson Biomedical, Inc., a Santa Barbara, Calif.-based research-stage company developing a subcutaneous ketamine treatment platform for pain management and mental health disorders, closed a $4.8m Series A round of financing. The round was l... |
| 02.02.2021 | Bexson Biomedical Raises $4.8 Million In Oversubscribed Series A |